CN106620976B - 一种丙酸氟替卡松定量吸入气雾剂 - Google Patents
一种丙酸氟替卡松定量吸入气雾剂 Download PDFInfo
- Publication number
- CN106620976B CN106620976B CN201611237839.2A CN201611237839A CN106620976B CN 106620976 B CN106620976 B CN 106620976B CN 201611237839 A CN201611237839 A CN 201611237839A CN 106620976 B CN106620976 B CN 106620976B
- Authority
- CN
- China
- Prior art keywords
- aerosol
- fluticasone propionate
- tank
- metered dose
- active ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000443 aerosol Substances 0.000 title claims abstract description 62
- 229960000289 fluticasone propionate Drugs 0.000 title claims abstract description 42
- WMWTYOKRWGGJOA-CENSZEJFSA-N fluticasone propionate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(OC(=O)CC)[C@@]2(C)C[C@@H]1O WMWTYOKRWGGJOA-CENSZEJFSA-N 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 claims abstract description 24
- 229910000838 Al alloy Inorganic materials 0.000 claims abstract description 17
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000003380 propellant Substances 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 229940071648 metered dose inhaler Drugs 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 208000006673 asthma Diseases 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 49
- 229940079593 drug Drugs 0.000 claims description 17
- 238000002048 anodisation reaction Methods 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000009472 formulation Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- YFMFNYKEUDLDTL-UHFFFAOYSA-N 1,1,1,2,3,3,3-heptafluoropropane Chemical compound FC(F)(F)C(F)C(F)(F)F YFMFNYKEUDLDTL-UHFFFAOYSA-N 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 239000000843 powder Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 14
- 238000001179 sorption measurement Methods 0.000 description 14
- 239000002245 particle Substances 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 11
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 11
- 238000007743 anodising Methods 0.000 description 10
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 9
- 229910052782 aluminium Inorganic materials 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 9
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 9
- 239000004810 polytetrafluoroethylene Substances 0.000 description 9
- 238000009835 boiling Methods 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 5
- 239000003054 catalyst Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 description 4
- 229920002313 fluoropolymer Polymers 0.000 description 4
- -1 Polytetrafluoroethylene Polymers 0.000 description 3
- 229960002714 fluticasone Drugs 0.000 description 3
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000010287 polarization Effects 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 229940124597 therapeutic agent Drugs 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 235000011089 carbon dioxide Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000010301 surface-oxidation reaction Methods 0.000 description 2
- 210000003437 trachea Anatomy 0.000 description 2
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- 239000000048 adrenergic agonist Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940124748 beta 2 agonist Drugs 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0065—Inhalators with dosage or measuring devices
Abstract
Description
类型 | PTFE罐 | 阳极化罐 |
罐中残留量(mg/个) | 0.68 | 0.08 |
类型 | PTFE罐 | 阳极化罐 |
罐中残留量(mg/个) | 0.14 | 0.10 |
氧化膜厚度(微米) | 5 | 10 | 15 | 20 |
罐内残留量(mg/个) | 0.66 | 0.09 | 0.06 | 0.07 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611237839.2A CN106620976B (zh) | 2016-12-28 | 2016-12-28 | 一种丙酸氟替卡松定量吸入气雾剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611237839.2A CN106620976B (zh) | 2016-12-28 | 2016-12-28 | 一种丙酸氟替卡松定量吸入气雾剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106620976A CN106620976A (zh) | 2017-05-10 |
CN106620976B true CN106620976B (zh) | 2020-01-07 |
Family
ID=58832328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611237839.2A Active CN106620976B (zh) | 2016-12-28 | 2016-12-28 | 一种丙酸氟替卡松定量吸入气雾剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106620976B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008102128A2 (en) * | 2007-02-19 | 2008-08-28 | Cipla Limited | Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
EP2316286A1 (en) * | 2009-10-29 | 2011-05-04 | Philip Morris Products S.A. | An electrically heated smoking system with improved heater |
JP2013221023A (ja) * | 2012-04-19 | 2013-10-28 | Yuichiro Kawahara | 光触媒効果を発現する機能性インプラント |
WO2016092108A3 (en) * | 2014-12-12 | 2016-07-28 | L'oreal | Deodorant aerosol equipped with a hollow dispensing head |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
CA2536876A1 (en) * | 2003-08-29 | 2005-03-17 | Glaxo Group Limited | Pharmaceutical metered dose inhaler and methods relating thereto |
MXPA06013189A (es) * | 2004-05-13 | 2007-02-14 | Chiesi Farma Spa | Productos medicinales de formulacion en aerosol que tienen estabilidad quimica mejorada. |
US10456335B2 (en) * | 2008-04-02 | 2019-10-29 | 90 Seconds To Wow, Llc | Oral hygiene compositions and methods |
CN104225739A (zh) * | 2014-09-30 | 2014-12-24 | 四川普锐特医药科技有限责任公司 | 一种医用定量吸入气雾剂 |
CN105963282B (zh) * | 2016-05-04 | 2019-04-19 | 四川普锐特医药科技有限责任公司 | 一种医用定量吸入气雾剂 |
-
2016
- 2016-12-28 CN CN201611237839.2A patent/CN106620976B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008102128A2 (en) * | 2007-02-19 | 2008-08-28 | Cipla Limited | Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
EP2316286A1 (en) * | 2009-10-29 | 2011-05-04 | Philip Morris Products S.A. | An electrically heated smoking system with improved heater |
JP2013221023A (ja) * | 2012-04-19 | 2013-10-28 | Yuichiro Kawahara | 光触媒効果を発現する機能性インプラント |
WO2016092108A3 (en) * | 2014-12-12 | 2016-07-28 | L'oreal | Deodorant aerosol equipped with a hollow dispensing head |
Also Published As
Publication number | Publication date |
---|---|
CN106620976A (zh) | 2017-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101238047B (zh) | 用于定量吸入器的隔热筒罐 | |
EP0536250B1 (en) | Aerosol drug formulations | |
ES2242822T3 (es) | Anticuerpo para uso en terapia. | |
BG64539B1 (bg) | Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения | |
JPH07502034A (ja) | 医薬 | |
CA3037107C (en) | Stable pharmaceutical compositions comprising salmeterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis) | |
Ostrander et al. | An in-vitro assessment of a NanoCrystal™ beclomethasone dipropionate colloidal dispersion via ultrasonic nebulization | |
CN103857388B (zh) | 包含硫酸沙丁胺醇的组合物 | |
SK138997A3 (en) | Metered dose inhaler for salmeterol | |
RO118173B1 (ro) | Compozitie de aerosol farmaceutic | |
SK281746B6 (sk) | Merací dávkovací inhalátor, neplnený merací dávkovací inhalátor a merací dávkovací inhalačný systém | |
BG65596B1 (bg) | Инхалатори с дозиране под налягане (mdi) | |
CZ326197A3 (cs) | Inhalátor, inhalační systém a jeho použití | |
US20100095963A1 (en) | Pharmaceutical compositions | |
WO2002085338A2 (en) | Ipratropium formulation for pulmonary inhalation | |
JP2023546025A (ja) | 加圧定量吸入器のための医薬製剤 | |
CN106620976B (zh) | 一种丙酸氟替卡松定量吸入气雾剂 | |
CN106581010B (zh) | 一种气溶胶制剂及定量吸入气雾剂 | |
CN109715160A (zh) | 药物组合物 | |
CN106619658B (zh) | 一种医用气溶胶制剂及定量吸入气雾剂 | |
GB2554091A (en) | Pharmaceutical composition | |
KR20070000476A (ko) | 압축화 계량된 도스흡입용 안정된 약제용액 제제 | |
KR20060136446A (ko) | 압축화 계량된 도스흡입용 안정된 약제용액 제제 | |
CN112438966B (zh) | 一种医用定量吸入气雾剂 | |
EP1785156B1 (en) | Metered dose inhaler containing an aerosol suspension formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: No. 15 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610000 Patentee after: Sichuan Pu et Pharmaceutical Co.,Ltd. Address before: No. 15 high tech Zone Gaopeng road in Chengdu city of Sichuan Province in 610000 Patentee before: SICHUAN PURUITE MEDICAL TECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: No. 566 Antaiwu Road, Gaoxin District, Chengdu, Sichuan Province, 611730 Patentee after: Sichuan Pu et Pharmaceutical Co.,Ltd. Address before: No.15 Gaopeng Avenue, high tech Zone, Chengdu, Sichuan 610000 Patentee before: Sichuan Pu et Pharmaceutical Co.,Ltd. |
|
CP02 | Change in the address of a patent holder |